| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 04/04/2006 | US7022715 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 04/04/2006 | US7022707 such as S-4-[(2-propylamino)carbonyl]oxybenzyl piperazine-1-thiocarboxylate for treatment of obesity and/or diabetes |
| 04/04/2006 | US7022705 such as (5RS)-3-(3-Fluoro-4-thiomorpholin-4-yl phenyl)-5-(1,2,3-triazol-1-ylmethyl)-4,5-dihydroisoxazole; antibiotics |
| 04/04/2006 | US7022696 Treatment of airway disorders |
| 04/04/2006 | US7022650 Herbicides for broadleaf/gramineous weeds among crop plants |
| 04/04/2006 | CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 04/04/2006 | CA2241787C Substituted aza- and diazacycloheptane and cyclooctane compounds and their use |
| 04/04/2006 | CA2198266C Novel benzimidazole derivatives |
| 04/04/2006 | CA2179284C Substituted unsymmetrical cyanine dyes with selected permeability |
| 04/04/2006 | CA2043976C Substituted phthalides and heterocyclic phthalides |
| 03/30/2006 | WO2006034474A2 Novel pyridine compounds, process for their preparation and compositions containing them |
| 03/30/2006 | WO2006034473A2 Novel pyrimidine compounds, process for their preparation and compositions containing them |
| 03/30/2006 | WO2006034419A2 Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
| 03/30/2006 | WO2006032541A1 Indol derivatives as inhibitors of soluble adenylyl cyclase |
| 03/30/2006 | WO2006032509A1 Indole derivatives, their manufacture and use as pharmaceutical agents |
| 03/30/2006 | WO2006032273A1 2-acylaminothiazole derivatives |
| 03/30/2006 | WO2006032218A1 Method for the preparation of rosiglitazone |
| 03/30/2006 | WO2006008545A3 Thiazole and isothiazole derivatives as protein kinase inhibitors |
| 03/30/2006 | WO2005120515A3 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease |
| 03/30/2006 | WO2005117867A3 Monocyclic heterocycles as kinase inhibitors |
| 03/30/2006 | WO2005019211A3 Biaryl heterocyclic compounds and methods of making and using the same |
| 03/30/2006 | WO2004058150A3 Anti-infectives |
| 03/30/2006 | US20060069256 Ophthalmic compositions for treating ocular hypertension |
| 03/30/2006 | US20060069253 Aryl-substituted heterocyclic enaminones |
| 03/30/2006 | US20060069147 hydrolase enzyme antagonists such as N-{(6S,9R,11R)-2-[5-4-fluoroophenyl)-1-methyl-1H-pyrazol-3-yl]-5,6,7,8,9,10-hexahydro-6,9-methanobenzo[a][8]annulen-11-yl}-N'-(2,2,2-trifiuoroethyl)sulfamide that inhibit processing of amyloid precursor protein, useful in treating or preventing Alzheimer's disease |
| 03/30/2006 | US20060069139 4-Methyl-5-(-2-nitrooxy-ethyl)-2-(1-nitrooxy-ethyl)-thiazole for example; compound forms a naturally occurring metabolite when NO is released; treating cardiovascular diseases, inflammation, psychiatric and neurological diseases, respiratory diseases, urogenital disorders |
| 03/30/2006 | US20060069138 Thiazole-based nitric oxide donors having alkyl substuent(s) and uses thereof |
| 03/30/2006 | US20060069135 Benzimidazole derivatives and their use for modulating the gaba-a receptor complex |
| 03/30/2006 | US20060069129 Chemokine receptor binding heterocyclic compounds |
| 03/30/2006 | US20060069109 Therapeutic agents |
| 03/30/2006 | US20060069103 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 03/30/2006 | US20060069102 such as 2-Morpholin-4-yl-thiazole-4-carboxylic acid (5,6-dimethyl-1H-benzoimidazol-2-yl)-amide, used for the treatment of dementia, amyotrophic lateral sclerosis, stroke, epilepsy, multiple sclerosis, myasthenia gravis, Huntington's, Alzheimer's, Parkinson's, Meniere's and Creutzfeld-Jacob Disease |
| 03/30/2006 | US20060069101 Prodrugs of protein tyrosine kinase inhibitors |
| 03/30/2006 | US20060069098 Bone disorders; reduce concentration of parathyroid hormone in blood |
| 03/30/2006 | US20060069090 Triazine compounds |
| 03/30/2006 | US20060069088 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 03/30/2006 | US20060069077 Receptor-type kinase modulators and methods of use |
| 03/30/2006 | US20060069034 Antipathogenic benzamide compounds |
| 03/30/2006 | CA2582492A1 Novel pyrimidine derivatives and their use |
| 03/30/2006 | CA2581657A1 Thrombopoietin receptor agonists |
| 03/30/2006 | CA2581623A1 Novel pyridine compounds, process for their preparation and compositions containing them |
| 03/30/2006 | CA2581492A1 Indol derivatives as inhibitors of soluble adenylyl cyclase |
| 03/30/2006 | CA2581338A1 Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
| 03/30/2006 | CA2581172A1 Carbonyl compound-containing drug and the use thereof |
| 03/30/2006 | CA2581105A1 2-acylaminothiazole derivatives |
| 03/30/2006 | CA2580725A1 Novel heterocyclic nf-kb inhibitors |
| 03/30/2006 | CA2580265A1 Amino-containing compounds which inhibit memapsin 2 beta-secretase activity and methods of use thereof |
| 03/30/2006 | CA2579907A1 Carbo- and hetero-cyclic antibiotics and use thereof |
| 03/30/2006 | CA2579412A1 Indole derivatives, their manufacture and use as pharmaceutical agents |
| 03/29/2006 | EP1640374A1 Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same |
| 03/29/2006 | EP1640367A1 Isoquinoline -1,3,4-trione, the synthetic method and the use thereof |
| 03/29/2006 | EP1638969A2 Cgrp receptor antagonists |
| 03/29/2006 | EP1638964A1 Novel compounds that modulate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 03/29/2006 | EP1638963A1 N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors |
| 03/29/2006 | EP1638960A2 Preparation of chemical compounds |
| 03/29/2006 | EP1638958A1 Zwitterionic non-linear optophores and devices incorporating same |
| 03/29/2006 | EP1638944A1 Tachykinin receptor antagonists |
| 03/29/2006 | EP1638942A1 Cis-2,4,5-triaryl-imidazolines |
| 03/29/2006 | EP1638570A1 Pyrimidine derivatives as cannabinoid receptor ligands |
| 03/29/2006 | EP0979823B1 Novel amide compounds and drugs containing the same |
| 03/29/2006 | CN1753955A 偶氮金属螯合染料及光学记录媒体 Azo metal chelate dyes and optical recording media |
| 03/29/2006 | CN1753890A Benzoazolypiperazine derivatives having MGLUR1- and MGLUR5-antagonistic activity |
| 03/29/2006 | CN1753889A Quinazoline compounds |
| 03/29/2006 | CN1753887A Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals |
| 03/29/2006 | CN1753886A Process for producing acid adduct salt of polyacidic base compound |
| 03/29/2006 | CN1753876A New pyridazin-3(2h)-one derivatives |
| 03/29/2006 | CN1753872A Process for the production of substituted nicotinic acid esters |
| 03/29/2006 | CN1753679A Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 03/29/2006 | CN1753677A Ocular hypotensive agent |
| 03/29/2006 | CN1753672A 4,5-diarylthiazole derivatives as cb-1 ligands |
| 03/29/2006 | CN1247574C Isoindolin-1-one glucokinase activators |
| 03/29/2006 | CN1247573C Method for preparing arylacetyl aminothiazole |
| 03/29/2006 | CN1247572C Method of producing nitroguanidine-and nitroenamine derivatives |
| 03/29/2006 | CN1247553C 2-imino-1,3-thiazine derivs. |
| 03/29/2006 | CN1247548C Cesium triazoleamide compounds and their preparation and use |
| 03/28/2006 | US7019327 Organic semiconductor polymer and organic thin film transistor using the same |
| 03/28/2006 | US7019147 E.,g.,1-[2-(5-Methoxy-benzoimidazol-1-yl)-quinolin-8-yl]-piperidin-4-ylamine; anticarcinogenic and -tumor agent; KDR tyrosine kinase inhibitors; (KDR=kinase inserrt domain recepter) |
| 03/28/2006 | US7019021 such as 2-(6-bromo-3-dimethylamino-2-methylphenylimino)imidazolidine; stress |
| 03/28/2006 | US7019009 Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activity |
| 03/28/2006 | US7019001 Substituted benzothiazole amide derivatives |
| 03/28/2006 | US7019000 administering nitrogen-sulfur compounds, e.g. 4,4-dithiodimorpholine to inhibit binding of the E6 protein by human papilloma virus; treatment of cervical cancer |
| 03/28/2006 | US7018998 substituted 4,5-dihydro-1H-benzo[b][1,4]-diazepin-2-one; amidation of a substituted monoprotected 1,2-diaminobenzene with an ester, deprotecting, cyclization; chronic neurological disorders, psychosis, schizophrenia, Alzheimer's disease |
| 03/28/2006 | US7018988 Pharmaceutically active pyrrolidine derivatives as Bax inhibitors |
| 03/28/2006 | US7018960 Formed by inter-molecular interaction of one or more keto-enol tautomeric compounds; for mechanical friction sliding members |
| 03/28/2006 | CA2309551C Aminothiazole inhibitors of cyclin dependent kinases |
| 03/28/2006 | CA2263417C Arylalkanoylpyridazines |
| 03/23/2006 | WO2006031852A1 Vanilloid receptor ligands and their use in treatments |
| 03/23/2006 | WO2006031782A2 Salvinorin derivatives as opioid receptor ligands |
| 03/23/2006 | WO2006030975A1 Piperidine derivatives and use thereof |
| 03/23/2006 | WO2006030807A1 Carbamoylpyridone derivative having hiv integrase inhibitory activity |
| 03/23/2006 | WO2006030032A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 03/23/2006 | WO2006029912A1 Indole derivatives as antiviral agents |
| 03/23/2006 | WO2006029863A1 Thiazolinone 2-substituted quinolines |
| 03/23/2006 | WO2006029862A1 Substituted hydantoins for the treatment of cancer |
| 03/23/2006 | WO2006029861A1 Thiazolinone 4-monosubstituted quinolines |
| 03/23/2006 | WO2006029829A1 Heteroaroyl-substituted serine amides utilized as herbicides |
| 03/23/2006 | US20060063940 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 03/23/2006 | US20060063843 Compounds for the treatment of inflammatory disorders |
| 03/23/2006 | US20060063818 Hydantoin derivatives and deren verwendung als tace inhibitoren |
| 03/23/2006 | US20060063817 e.g. 8-{2-[1,1-dimethyl-3-(6-methyl-2-oxo-2,3-dihydro-benzimidazol-1-yl)-propylamino]-1-hydroxy-ethyl}-6-hydroxy-4H-benzo[1,4]oxazin-3-one; adrenoreceptor modulator (agonist); respiratory system doseases: COPD, asthma, cystic fibrosis; bronchitis; bronchiectasis; Adult Respiratory Distress Syndrome |